Literature DB >> 1354783

Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency.

J P Shield1, S Strobel, R J Levinsky, G Morgan.   

Abstract

Recurrent bacterial infections, lymphadenopathy, and failure to thrive are unlikely to be attributed to immune deficiency if they occur in the presence of hypergammaglobulinaemia, and other explanations will usually be sought. We describe eight patients who presented with all these features in infancy or early childhood. Deficiencies of immunoglobulin and antibody production were initially discounted, and the children were referred for investigation of possible lymphoma, autoimmune disease, or chronic viral infection. The patients were later referred to us for more detailed immunological investigation, which revealed low levels of IgG2 and poor specific antibody production to common pathogens. Treatment with intravenous immunoglobulin resulted in resolution of signs and symptoms in all patients. Thus we have shown that hypergammaglobulinaemia does not preclude the presence of immunoglobulin/antibody deficiency. We suggest that investigation of children with high levels of IgG and features of immunodeficiency should include IgG subclass analysis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354783     DOI: 10.1016/0140-6736(92)91769-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.

Authors:  Hikmet G Tanyildiz; Handan Dincaslan; Gulsan Yavuz; Emel Unal; Aydan Ikinciogulları; Figen Dogu; Nurdan Tacyildiz
Journal:  J Clin Immunol       Date:  2016-08-04       Impact factor: 8.317

Review 2.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

3.  CD40-activated human naive surface IgD+ B cells produce IgG2 in response to activated T-cell supernatant.

Authors:  C Servet-Delprat; J M Bridon; D Blanchard; J Banchereau; F Brière
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

4.  Humoral immunity and bronchiectasis.

Authors:  A Stead; J G Douglas; C J Broadfoot; E R Kaminski; R Herriot
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

5.  Defective IgG2 response to Pneumovax in HIV seropositive patients.

Authors:  D J Unsworth; D Rowen; C Carne; C Sonnex; T Baglin; D L Brown
Journal:  Genitourin Med       Date:  1993-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.